Raily Aesthetic Medicine Outlines Board and Committee Structure

Raily Aesthetic Medicine International Holdings Limited ( (HK:2135) ) has shared an announcement.

Raily Aesthetic Medicine International Holdings Limited has disclosed the composition of its board of directors, naming Fu Haishu as chairman, Song Jianliang as chief executive officer, and Wang Ying as an executive director. The board also includes three independent non-executive directors: Lin Hai, Yang Xiaofen and Liu Teng.

The company has established four key board committees — audit, remuneration, nomination and strategic investment — and detailed which directors chair and sit on each body. The clarified governance structure is intended to delineate oversight responsibilities and decision-making roles, signaling a focus on formalized corporate governance for investors and other stakeholders.

The most recent analyst rating on (HK:2135) stock is a Hold with a HK$0.15 price target. To see the full list of analyst forecasts on Raily Aesthetic Medicine International Holdings Limited stock, see the HK:2135 Stock Forecast page.

More about Raily Aesthetic Medicine International Holdings Limited

Raily Aesthetic Medicine International Holdings Limited is a Cayman Islands–incorporated company listed in Hong Kong under stock code 2135. The group operates in the aesthetic medicine sector, focusing on medical beauty services in mainland China, with corporate governance structured around a board comprising executive and independent non-executive directors.

Average Trading Volume: 431,953

Technical Sentiment Signal: Hold

Current Market Cap: HK$81.33M

Learn more about 2135 stock on TipRanks’ Stock Analysis page.